Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹71Cr
Medical Accessories/Disposables
Rev Gr TTM
Revenue Growth TTM
-21.04%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MHHL
VS
| Quarter | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 3.2 | 16.8 | -3.8 | -22.6 | 24.1 | 77.3 | 14.6 | 2.1 | 5.9 | -9.7 | -22.4 | -19.6 |
| 65 | 60 | 60 | 47 | 79 | 94 | 85 | 94 | 92 | 82 | 80 | 76 |
Operating Profit Operating ProfitCr |
| 4.5 | 17.0 | 8.2 | 15.8 | 2.2 | 5.4 | 8.0 | 7.6 | 6.3 | 10.0 | -4.8 | -3.2 |
Other Income Other IncomeCr | 6 | 0 | 0 | 1 | 6 | 6 | 1 | 4 | 4 | 1 | 10 | 3 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 | 2 | 2 |
Depreciation DepreciationCr | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
| 7 | 10 | 4 | 8 | 6 | 10 | 5 | 9 | 8 | 9 | 4 | -2 |
| 1 | 0 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 2 | 1 | 0 |
|
Growth YoY PAT Growth YoY% | -39.4 | 109.5 | -144.1 | -40.6 | 225.4 | 15.5 | 1.8 | 0.6 | 233.1 | -5.6 | -81.4 | -181.1 |
| 4.3 | 10.4 | -2.0 | 7.9 | 2.0 | 5.2 | 1.8 | 5.1 | 5.6 | 5.3 | 1.4 | -5.4 |
| 1.6 | 4.1 | -0.7 | 2.4 | 0.7 | 2.8 | 0.9 | 2.8 | 3.0 | 2.7 | 0.6 | -2.2 |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -12.8 | -12.0 | 6.0 | -0.8 | 40.8 | 4.0 | -15.9 | -10.7 |
| 152 | 127 | 119 | 120 | 126 | 179 | 186 | 156 | 156 |
Operating Profit Operating ProfitCr |
| 10.1 | 13.5 | 8.4 | 12.8 | 7.9 | 6.6 | 7.0 | 7.1 | -4.0 |
Other Income Other IncomeCr | 1 | 1 | 6 | 0 | 7 | 6 | 8 | 11 | 12 |
Interest Expense Interest ExpenseCr | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 4 |
Depreciation DepreciationCr | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 |
| 7 | 10 | 8 | 8 | 9 | 11 | 13 | 8 | 3 |
| 2 | 3 | 1 | 2 | 3 | 4 | 3 | 3 | 1 |
|
| | 45.8 | -10.8 | -5.3 | -1.8 | 11.8 | 57.6 | -45.3 | -149.9 |
| 3.0 | 5.0 | 5.0 | 4.5 | 4.5 | 3.5 | 5.4 | 3.5 | -1.9 |
| 2.8 | 4.0 | 3.6 | 3.4 | 3.1 | 3.7 | 5.9 | 3.2 | -1.6 |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 |
Current Liabilities Current LiabilitiesCr | 49 | 45 | 45 | 53 | 64 | 36 | 29 | 56 |
Non Current Liabilities Non Current LiabilitiesCr | 30 | 23 | 17 | 16 | 10 | 13 | 11 | 7 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 70 | 67 | 70 | 78 | 100 | 87 | 92 | 116 |
Non Current Assets Non Current AssetsCr | 68 | 66 | 64 | 69 | 57 | 51 | 48 | 52 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 3 | 14 | 16 | 10 | -5 | 26 | 14 | 30 |
Investing Cash Flow Investing Cash FlowCr | -6 | -4 | -2 | -8 | 8 | -6 | -1 | -29 |
Financing Cash Flow Financing Cash FlowCr | 5 | -12 | -14 | -3 | -3 | -20 | -10 | 8 |
|
Free Cash Flow Free Cash FlowCr | -3 | 10 | 14 | 2 | 3 | 23 | 12 | 5 |
| 68.4 | 193.4 | 248.6 | 164.4 | -77.6 | 382.1 | 131.5 | 519.3 |
CFO To EBITDA CFO To EBITDA% | 20.1 | 71.1 | 149.4 | 57.7 | -43.9 | 203.8 | 100.8 | 255.9 |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 125 | 62 | 21 | 44 | 50 | 92 | 96 | 110 |
Price To Earnings Price To Earnings | 25.1 | 8.5 | 3.2 | 7.4 | 8.8 | 13.6 | 9.0 | 18.7 |
Price To Sales Price To Sales | 0.7 | 0.4 | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 |
Price To Book Price To Book | 2.2 | 0.9 | 0.3 | 0.6 | 0.6 | 1.0 | 1.0 | 1.0 |
| 10.1 | 5.3 | 5.0 | 4.9 | 8.7 | 9.3 | 8.2 | 10.9 |
Profitability Ratios Profitability Ratios |
| 21.2 | 28.6 | 28.2 | 36.8 | 33.6 | 27.3 | 25.4 | 31.2 |
| 10.1 | 13.5 | 8.4 | 12.8 | 7.9 | 6.6 | 7.0 | 7.1 |
| 3.0 | 5.0 | 5.0 | 4.5 | 4.5 | 3.5 | 5.4 | 3.5 |
| 12.8 | 14.0 | 11.2 | 10.4 | 9.6 | 12.6 | 14.3 | 8.3 |
| 8.7 | 11.1 | 9.1 | 8.0 | 7.3 | 7.6 | 10.7 | 5.6 |
| 3.6 | 5.5 | 4.9 | 4.2 | 3.9 | 4.9 | 7.7 | 3.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Founded in **2009** and headquartered in **Indore, Madhya Pradesh**, Mohini Health & Hygiene Limited (MHHL) has evolved from a cotton waste recycler into a premier manufacturer and exporter of health, hygiene, and medical textile products. The company operates a centralized, state-of-the-art manufacturing facility in **Pithampur**, strategically located near raw material sources and the **Nhava Sheva** seaport to facilitate its robust export business.
In **March 2026**, MHHL achieved a landmark regulatory milestone by becoming the first entity in India to be granted the **All India First License** by the **Bureau of Indian Standards (BIS)** for Medical Textiles Absorbent Cotton (**IS 16468: 2016**). This certification, valid until **March 2031**, positions the company as a quality leader in a sector increasingly driven by hygiene awareness and stringent healthcare standards.
---
### **Product Portfolio & Manufacturing Capabilities**
MHHL operates a single reporting segment focused on high-quality medical consumables. The company leverages India’s position as a global cotton powerhouse (**24% of global production**) to source "White Gold" and process it into value-added medical goods.
**Core Product Segments:**
* **Surgical & Bleached Cotton:** 100% Absorbent Bleached Cotton and Comber (Conventional and Organic), available in sterile and non-sterile formats.
* **Hygiene & Personal Care:** Cotton ear buds, cotton balls, and makeup pads.
* **Medical Consumables:** Gamjee rolls, zig-zag cotton, and protective gear including **N95 and Surgical Masks**.
* **Future Pipeline:** Management is currently developing a pipeline of over **100 new products** within the surgical and consumables range to deepen market penetration.
**Operational Infrastructure:**
| Facility Component | Capacity / Specification |
| :--- | :--- |
| **Bleaching Capacity** | **~11,000 Metric Tons** per annum |
| **Surgical Cotton Products** | **2,400 Tonnes** per annum |
| **Warehouse Space** | **1,440 Sq. m** for finished goods |
| **Workforce** | **250+ Employees** |
---
### **Strategic Growth: Diversification & Backward Integration**
The company is transitioning from a pure-play manufacturer into a diversified industrial group. The primary objective is to maintain **10% year-on-year growth** in both top-line and bottom-line performance.
* **Inorganic Expansion (Winsome Yarns Acquisition):** In **April 2026**, MHHL was declared the **Successful Resolution Applicant (SRA)** for **Winsome Yarns Limited**. This **INR 162.90 Crore** resolution plan integrates manufacturing capabilities in cotton yarn, knitting, and **hydropower**, marking a significant move into renewable energy and textile manufacturing.
* **Renewable Energy Transition:** To mitigate rising energy costs, MHHL is installing a **Captive Solar Power System** in the **Shajapur District, Madhya Pradesh**. The company amended its Memorandum of Association in **May 2025** to include captive power consumption as a core operational pillar.
* **Global Footprint:** Awarded the **Three Star Export House** certificate (valid until **March 2028**), MHHL exports to **Germany, Italy, Spain, Russia, China, Brazil, and Mexico**. To support this, a new **Marketing Office in Mumbai** was established in **October 2025**.
---
### **Financial Performance & Capital Structure**
While MHHL saw a revenue contraction in **FY25** due to fluctuating sales prices and accounting adjustments for goods in transit, the company has aggressively focused on deleveraging its balance sheet.
**Key Financial Metrics:**
| Metric (INR Crore) | FY 2024-25 (Audited) | FY 2023-24 (Audited) | Variance |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **178.67** | **207.62** | -13.94% |
| **Total Expenses** | **163.73** | **194.22** | -15.70% |
| **Net Worth** | **105.47** | **100.45** | +5.00% |
| **Total Borrowings** | **1.75** | **5.58** | -68.67% |
| **Finance Cost** | **3.17** | **4.24** | -25.28% |
**Fundraising & Capital Allocation:**
* **Authorized Capital:** Increased to **INR 25 Crores** in **2025**.
* **Convertible Warrants:** Issued **67,00,000 warrants** at **INR 62 per warrant**, aggregating **INR 41.54 Crores**.
* **Use of Proceeds:** Funds are earmarked for the expansion of the subsidiary **Mohini Active Life Private Limited**, solar plant installation, and working capital.
---
### **Risk Profile & Mitigation Framework**
MHHL manages a complex risk environment stemming from historical operational disruptions and ongoing legal transitions.
**1. Audit Qualifications & Insurance Claims:**
Following a major fire in **May 2021**, the company booked an insurance claim of **INR 25.04 Crore**. Statutory auditors have maintained a **Qualified Opinion** because the final insurance survey is pending. In **FY25**, the company proactively wrote off **INR 6.18 Crore** as an extraordinary item related to this claim.
**2. Credit Ratings & Solvency:**
As of **February 2026**, **India Ratings and Research (Ind-Ra)** affirmed a rating of **IND BBB-** but revised the outlook to **Negative**, citing evolving financial conditions. However, the company successfully stayed a **Section 9** insolvency petition in **May 2024** through a formal settlement deed with an operational creditor.
**3. Market & Operational Risks:**
* **Raw Material Volatility:** Managed through a **strategic stocking policy** for raw cotton.
* **Currency Risk:** The company recognized notional losses on open forward contracts (**INR 12.53 Lakhs** in FY25) and utilizes **measured hedging** to protect export margins.
* **Capacity Recovery:** Management confirms that the bleaching unit, previously disrupted by fire, has returned to **optimum capacity utilization** as of late **2024**.
---
### **Investment Thesis Summary**
Mohini Health & Hygiene Limited presents a recovery and growth narrative. By securing the **first-ever BIS license** for absorbent cotton in India, the company has created a significant competitive moat in the domestic institutional market. The acquisition of **Winsome Yarns** and the shift toward **captive solar power** indicate a long-term strategy to control input costs and diversify revenue streams. While audit qualifications regarding the 2021 fire claim remain a point of scrutiny, the aggressive **68% reduction in debt** and the transition toward a **Three Star Export House** status signal a strengthening financial and operational foundation.